Cargando…

Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use

AIM: To characterize the usage profile and the factors associated with the prolonged use of proton pump inhibitor drugs in a community pharmacy. METHODOLOGY: This is a cross-sectional, prospective and observational study involving interviews with 410 patients who acquired PPI for their own use from...

Descripción completa

Detalles Bibliográficos
Autores principales: de Araújo, Lorena Maria Lima, de Moura Lopes, Maria Vivyanne, de Arruda, Rafael Silva, Martins, Rand Randall, Oliveira, Antonio Gouveia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191994/
https://www.ncbi.nlm.nih.gov/pubmed/34111166
http://dx.doi.org/10.1371/journal.pone.0252785
_version_ 1783705964417908736
author de Araújo, Lorena Maria Lima
de Moura Lopes, Maria Vivyanne
de Arruda, Rafael Silva
Martins, Rand Randall
Oliveira, Antonio Gouveia
author_facet de Araújo, Lorena Maria Lima
de Moura Lopes, Maria Vivyanne
de Arruda, Rafael Silva
Martins, Rand Randall
Oliveira, Antonio Gouveia
author_sort de Araújo, Lorena Maria Lima
collection PubMed
description AIM: To characterize the usage profile and the factors associated with the prolonged use of proton pump inhibitor drugs in a community pharmacy. METHODOLOGY: This is a cross-sectional, prospective and observational study involving interviews with 410 patients who acquired PPI for their own use from community pharmacies. To characterize the factors associated with the prolonged use of PPI, a multivariate logistic regression model was used. RESULTS: Pantoprazole (42.7%) and omeprazole (31%) were the most acquired PPIs, prescribed mainly by gastroenterologists (49.5%). They are used in the morning, especially for gastrointestinal symptoms, however, they had been consumed for more than 5 years in 30% of cases. The factors associated with prolonged use are old age (OR 1.03 CI95% 1.01–1.05), body mass index (OR 1.07 CI95% 1.01–1.12), use of non-steroidal anti-inflammatories (OR 3.18 CI95% 1.20–8.43) and selective serotonin reuptake inhibitors (OR 3.5 95% CI 1.39–8.88). CONCLUSION: PPIs are adequate in terms of indication and form of use, however, prolonged use associated with old age, being overweight and use of anti-inflammatories and antidepressants is frequent.
format Online
Article
Text
id pubmed-8191994
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-81919942021-06-10 Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use de Araújo, Lorena Maria Lima de Moura Lopes, Maria Vivyanne de Arruda, Rafael Silva Martins, Rand Randall Oliveira, Antonio Gouveia PLoS One Research Article AIM: To characterize the usage profile and the factors associated with the prolonged use of proton pump inhibitor drugs in a community pharmacy. METHODOLOGY: This is a cross-sectional, prospective and observational study involving interviews with 410 patients who acquired PPI for their own use from community pharmacies. To characterize the factors associated with the prolonged use of PPI, a multivariate logistic regression model was used. RESULTS: Pantoprazole (42.7%) and omeprazole (31%) were the most acquired PPIs, prescribed mainly by gastroenterologists (49.5%). They are used in the morning, especially for gastrointestinal symptoms, however, they had been consumed for more than 5 years in 30% of cases. The factors associated with prolonged use are old age (OR 1.03 CI95% 1.01–1.05), body mass index (OR 1.07 CI95% 1.01–1.12), use of non-steroidal anti-inflammatories (OR 3.18 CI95% 1.20–8.43) and selective serotonin reuptake inhibitors (OR 3.5 95% CI 1.39–8.88). CONCLUSION: PPIs are adequate in terms of indication and form of use, however, prolonged use associated with old age, being overweight and use of anti-inflammatories and antidepressants is frequent. Public Library of Science 2021-06-10 /pmc/articles/PMC8191994/ /pubmed/34111166 http://dx.doi.org/10.1371/journal.pone.0252785 Text en © 2021 de Araújo et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
de Araújo, Lorena Maria Lima
de Moura Lopes, Maria Vivyanne
de Arruda, Rafael Silva
Martins, Rand Randall
Oliveira, Antonio Gouveia
Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use
title Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use
title_full Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use
title_fullStr Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use
title_full_unstemmed Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use
title_short Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use
title_sort proton pump inhibitor and community pharmacies: usage profile and factors associated with long-term use
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191994/
https://www.ncbi.nlm.nih.gov/pubmed/34111166
http://dx.doi.org/10.1371/journal.pone.0252785
work_keys_str_mv AT dearaujolorenamarialima protonpumpinhibitorandcommunitypharmaciesusageprofileandfactorsassociatedwithlongtermuse
AT demouralopesmariavivyanne protonpumpinhibitorandcommunitypharmaciesusageprofileandfactorsassociatedwithlongtermuse
AT dearrudarafaelsilva protonpumpinhibitorandcommunitypharmaciesusageprofileandfactorsassociatedwithlongtermuse
AT martinsrandrandall protonpumpinhibitorandcommunitypharmaciesusageprofileandfactorsassociatedwithlongtermuse
AT oliveiraantoniogouveia protonpumpinhibitorandcommunitypharmaciesusageprofileandfactorsassociatedwithlongtermuse